The beneficial effect of Batroxobin on blood loss reduction in spinal fusion surgery: a prospective, randomized, double-blind, placebo-controlled study
- 27 February 2015
- journal article
- research article
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 135 (4) , 491-497
Abstract
Our objective was to evaluate the efficacy and safety of Batroxobin on blood loss during spinal operations.Keywords
This publication has 27 references indexed in Scilit:
- A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgeryBMC Surgery, 2010
- Blood Loss in Major Spine SurgerySpine, 2010
- Can We Safely Reduce Blood Loss During Lumbar Pedicle Subtraction Osteotomy Procedures Using Tranexamic Acid or Aprotinin?Spine, 2010
- Blood Coagulation: Hemostasis and Thrombin RegulationAnesthesia & Analgesia, 2009
- Are batroxobin agents effective for perioperative hemorrhage in thoracic surgery? A systematic review of randomized controlled trialsBlood Coagulation & Fibrinolysis, 2009
- Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac SurgeryCirculation, 2007
- Elective surgery days after myocardial infarction: clinical and ethical considerationsJournal of Clinical Anesthesia, 2006
- High prevalence of abnormal preoperative coagulation tests in patients with adolescent idiopathic scoliosisJournal of Thrombosis and Haemostasis, 2005
- The association of biologically active lipids with the development of transfusion‐related acute lung injury: a retrospective studyTransfusion, 1997
- Coagulopathy After Reinfusion of Autologous Scavenged Red Blood CellsAnesthesia & Analgesia, 1992